ARTICLE | Company News
Gaurdant, Softbank form JV for liquid biopsy technology
May 12, 2017 6:49 PM UTC
Guardant Health Inc. (Redwood City, Calif.) and SoftBank Group Corp. (Tokyo:9984) formed a JV to commercialize Guardant's liquid biopsy technology in Asia, the Middle East and Africa. The JV will be located outside the U.S. Guardant markets Guardant360, a non-invasive pan-cancer blood test that detects genomic alterations linked to cancer. ...
BCIQ Company Profiles